Antimicrobials News

The consumption of a group of first- and second-line antibiotics with a higher potential for resistance increased by approximately 91% between 2000 and 2015, according to a study in The Lancet Infectious Diseases.

Some active ingredients in mouthwash are effective against pneumonia-causing bacteria, according to the results of an in vitro study presented during ASM Microbe, which is being held virtually.

A quality improvement intervention led to a 7% sustained reduction in antibiotic prescribing for pediatric acute respiratory tract infections at nearly two dozen U.S. practices, researchers reported in Pediatrics.

A study published in Infection Control & Hospital Epidemiology reported “widespread” use of empirical antibiotics for patients with COVID-19 at a New York hospital, and that coinfections among COVID-19 patients were uncommon.

Treatment opportunities for novel gram-negative antibiotics are relatively infrequent in hospitals — representing just 39 to 138 days of therapy per 10,000 encounters, according to a study.

Researchers detected secondary multidrug-resistant isolates with distinct resistance genes in nearly half of cohorted patients in a long-term acute-care hospital, suggesting cross-transmission, according to study findings.

Nearly 20% of patients treated for pneumonia did not display pneumonia symptoms on their first day of treatment, but antibiotics were used for 3 days or more after symptoms ceased in one-third of patients, according to a large cohort study.

Unpasteurized, or raw, milk can serve as a reservoir for antimicrobial-resistant genes, according to a study published in Microbiome.

Two dozen biopharmaceutical companies recently announced the launch of the AMR Action Fund, a collaboration they hope will lead to the development of two to four new antibiotics by 2030.

IDWeek organizers decided unanimously to convert this year’s meeting to a completely virtual event over concerns about COVID-19.